Contribution of secretory antibodies to intestinal mucosal immunity against helicobacter pylori

Infection and Immunity

Volumn 81, Issue 10, 2013, Pages 3880-3893

  Gorrell, Rebecca J ^a,b,d   Wijburg, Odilia L C ^a   Pedersen, John S ^c   Walduck, Anna K ^a,e   Kwok, Terry ^d   Strugnell, Richard A ^a   Robins Browne, Roy M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Tissupath Pty Ltd   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; SECRETORY ANTIBODY; SECRETORY COMPONENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL LOAD; CONTROLLED STUDY; DUODENUM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOHISTOLOGY; LONGITUDINAL STUDY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; STOMACH ANTRUM; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, POLYMERIC IMMUNOGLOBULIN;

EID: 84884378097     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01424-12     Document Type: Article

References (66)

1. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. 2001. The design of vaccines against Helicobacter pylori and their development. Annu. Rev. Immunol. 19:523-563.
2. Garhart CA, Redline RW, Nedrud JG, Czinn SJ. 2002. Clearance of Helicobacter pylori infection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect. Immun. 70:3529-3538.
3. Raghavan S, Hjulstrom M, Holmgren J, Svennerholm AM. 2002. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect. Immun. 70: 6383-6388.
4. Aebischer T, Schmitt A, Walduck AK, Meyer TF. 2005. Helicobacter pylori vaccine development: facing the challenge. Int. J. Med. Microbiol. 295:343-353.
5. Akhiani AA, Stensson A, Schon K, Lycke NY. 2005. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. J. Immunol. 174:8144-8153.
6. Akhiani AA, Schon K, Franzen LE, Pappo J, Lycke N. 2004. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. J. Immunol. 172:5024-5033.
7. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG. 1999. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell. Immunol. 191:74-80.
8. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:2277-2288.
9. Garhart CA, Nedrud JG, Heinzel FP, Sigmund NE, Czinn SJ. 2003. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. Infect. Immun. 71:3628-3633.
10. Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192:475-482.
11. Suto A, Nakajima H, Ikeda K, Kubo S, Nakayama T, Taniguchi M, Saito Y, Iwamoto I. 2002. CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. Blood 99:555-560.
12. Brandtzaeg P. 1983. Immunohistochemical characterization of intracellular J-chain and binding site for secretory component (SC) in human immunoglobulin (Ig)-producing cells. Mol. Immunol. 20:941-966.
13. Rinkenberger JL, Wallin JJ, Johnson KW, Koshland ME. 1996. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 5:377-386.
14. Piskurich JF, Youngman KR, Phillips KM, Hempen PM, Blanchard MH, France JA, Kaetzel CS. 1997. Transcriptional regulation of the human polymeric immunoglobulin receptor gene by interferon-gamma. Mol. Immunol. 34:75-91.
15. Kaneko T, Ota H, Hayama M, Akamatsu T, Katsuyama T. 2000. Helicobacter pylori infection produces expression of a secretory component in gastric mucous cells. Virchows Arch. 437:514-520.
16. Isaacson P. 1982. Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut 23:578-588.
17. Takemura K, Hirokawa K, Esaki Y, Mishima Y. 1990. Distribution of immunoglobulins and secretory component in gastric cancer of the aged. Cancer 66:2168-2173.
18. Gologan A, Acquafondata M, Dhir R, Sepulveda AR. 2008. Polymeric immunoglobulin receptor-negative tumors represent a more aggressive type of adenocarcinomas of distal esophagus and gastroesophageal junction. Arch. Pathol. Lab. Med. 132:1295-1301.
19. Spohn M, McColl I. 1979. Studies on human gastric mucosal immunoglobulin A. II. Further evidence for the absence of the secretory component from the predominant immunoglobulin A of human gastric mucus. Biochim. Biophys. Acta 576:9-16.
20. Spohn M, McColl I. 1979. Studies on human gastric mucosal immunoglobulin A. Biochim. Biophys. Acta 576:1-8.
21. Ahlstedt I, Lindholm C, Lonroth H, Hamlet A, Svennerholm AM, Quiding-Jarbrink M. 1999. Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection. Infect. Immun. 67:4921-4925.
22. El Kaissouni J, Bene MC, Faure GC. 1998. Activation of epithelial cells in gastritis. Digestion 59:53-59.
23. Handa Y, Saitoh T, Kawaguchi M, Misaka R, Tsurui M, Ohno H, Morita S, Sanji T, Tani Y, Sakai Y, Umezawa H. 1999. Production of secretory component and pathogenesis of gastric cancer in Helicobacter pylori-infected stomach. J. Gastroenterol. 34(Suppl 11):37-42.
24. Meyer F, Wilson KT, James SP. 2000. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect. Immun. 68:6265-6272.
25. Berstad AE, Kilian M, Valnes KN, Brandtzaeg P. 1999. Increased mucosal production of monomeric IgA1 but no IgA1 protease activity in Helicobacter pylori gastritis. Am. J. Pathol. 155:1097-1104.
26. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301:1099-1102.
27. Quiding-Järbrink M, Sundström P, Lundgren A, Hansson M, Bäckström M, Johansson C, Enarsson K, Hermansson M, Johnsson E, Svennerholm AM. 2009. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients. Clin. Immunol. 131:463-471.
28. Birkholz S, Schneider T, Knipp U, Stallmach A, Zeitz M. 1998. Decreased Helicobacter pylori-specific gastric secretory IgA antibodies in infected patients. Digestion 59:638-645.
29. Shirai Y, Wakatsuki Y, Kusumoto T, Nakata M, Yoshida M, Usui T, Iizuka T, Kita T. 2000. Induction and maintenance of immune effector cells in the gastric tissue of mice orally immunized to Helicobacter pylori requires salivary glands. Gastroenterology 118:749-759.
30. Dalenbäck J, Abrahamson H, Björnson E, Fändriks L, Mattsson A, Olbe L, Svennerholm A, Sjövall H. 1998. Human duodenogastric reflux, retroperistalsis, and MMC. Am. J. Physiol. 275:R762-R769.
31. Uren TK, Johansen FE, Wijburg OL, Koentgen F, Brandtzaeg P, Strugnell RA. 2003. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J. Immunol. 170:2531-2539.
32. Gorrell RJ, Robins-Browne RM. 2009. Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity. Infect. Immun. 77:5116-5129.
33. Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. 2004. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J. Clin. Microbiol. 42:2766-2768.
34. Dixon MF, Genta RM, Yardley JH, Correa P. 1996. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20:1161-1181.
35. Tan MP, Kaparakis M, Galic M, Pedersen J, Pearse M, Wijburg OL, Janssen PH, Strugnell RA. 2007. Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach. Appl. Environ. Microbiol. 73:1010-1013.
36. Hitchcock PJ, Brown TM. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
37. Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P, Strugnell RA. 2006. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J. Exp. Med. 203:21-26.
38. Johansen FE, Pekna M, Norderhaug IN, Haneberg B, Hietala MA, Krajci P, Betsholtz C, Brandtzaeg P. 1999. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J. Exp. Med. 190:915-922.
39. Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A. 2004. Innate immune response in Th1-and Th2-dominant mouse strains. Shock 22: 460-466.
40. Hodgkin PD, Yamashita LC, Seymour B, Coffman RL, Kehry MR. 1991. Membranes from both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig. J. Immunol. 147:3696-3702.
41. Kelly KA. 1980. Gastric emptying of liquids and solids: roles of proximal and distal stomach. Am. J. Physiol. 239:G71-G76.
42. Luiking YC, van der Reijden AC, van Berge Henegouwen GP, Akkermans LM. 1998. Migrating motor complex cycle duration is determined by gastric or duodenal origin of phase III. Am. J. Physiol. 275:G1246-G1251.
43. Mellander A, Mattsson A, Svennerholm AM, Sjovall H. 1997. Relationship between interdigestive motility and secretion of immunoglobulin A in human proximal small intestine. Dig. Dis. Sci. 42:554-567.
44. Castedal M, Abrahamsson H. 2001. High-resolution analysis of the duodenal interdigestive phase III in humans. Neurogastroenterol. Motil. 13: 473-481.
45. Bercik P, Verdu EF, Foster JA, Lu J, Scharringa A, Kean I, Wang L, Blennerhassett P, Collins SM. 2009. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:R587-R594.
46. Testoni PA, Bagnolo F, Bologna P, Colombo E, Bonassi U, Lella F, Buizza M. 1996. Higher prevalence of Helicobacter pylori infection in dyspeptic patients who do not have gastric phase III of the migrating motor complex. Scand. J. Gastroenterol. 31:1063-1068.
47. Bogstedt AK, Nava S, Wadstrom T, Hammarstrom L. 1996. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin. Exp. Immunol. 105:202-204.
48. Shimizu T, Akamatsu T, Sugiyama A, Ota H, Katsuyama T. 1996. Helicobacter pylori and the surface mucous gel layer of the human stomach. Helicobacter 1:207-218.
49. Henriksnäs J, Phillipson M, Storm M, Engstrand L, Soleimani M, Holm L. 2006. Impaired mucus-bicarbonate barrier in Helicobacter pyloriinfected mice. Am. J. Physiol. Gastrointest. Liver Physiol. 291:G396-G403.
50. Newton JL, Jordan N, Oliver L, Strugala V, Pearson J, James OF, Allen A. 1998. Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut 43:470-475.
51. McSweegan E, Burr DH, Walker RI. 1987. Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells. Infect. Immun. 55:1431-1435.
52. Sjovall H. 2011. Meaningful or redundant complexity-mechanisms behind cyclic changes in gastroduodenalpHin the fasting state. Acta Physiol. (Oxf) 201:127-131.
53. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Muller A. 2011. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Gastroenterology 140:199-209.
54. Carrick J, Lee A, Hazell S, Ralston M, Daskalopoulos G. 1989. Campylobacter pylori, duodenal ulcer, and gastric metaplasia: possible role of functional heterotopic tissue in ulcerogenesis. Gut 30:790-797.
55. Johan G, Offerhaus A, Molyvas EN, Hoedemaeker PJ. 1990. Helicobacter pylori infection of gastric mucin cell metaplasia: the duodenum revisited. J. Pathol. 162:239-243.
56. Pietroiusti A, Luzzi I, Gomez MJ, Magrini A, Bergamaschi A, Forlini A, Galante A. 2005. Helicobacter pylori duodenal colonization is a strong risk factor for the development of duodenal ulcer. Aliment. Pharmacol. Ther. 21:909-915.
57. Sait LC, Galic M, Price JD, Simpfendorfer KR, Diavatopoulos DA, Uren TK, Janssen PH, Wijburg OL, Strugnell RA. 2007. Secretory antibodies reduce systemic antibody responses against the gastrointestinal commensal flora. Int. Immunol. 19:257-265.
58. Strömberg E, Edebo A, Svennerholm AM, Lindholm C. 2003. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori- infected duodenal ulcer patients. Clin. Diagn. Lab. Immunol. 10:116-124.
59. Arnold IC, Hitzler I, Müller A. 2012. The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front. Cell. Infect. Microbiol. 2:10. doi:10.3389/fcimb.2012.00010.
60. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, Zhao ZZ, Montgomery GW, Green AC, Hayward NK, Webb PM. 2010. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 139:73-83.
61. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyren O. 2004. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J. Natl. Cancer Inst. 96:388-396.
62. Sonnenberg A, Lash RH, Genta RM. 2010. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 139: 1894-1901.
63. Perry S, de Jong BC, Solnick JV, de la Luz Sanchez M, Yang S, Lin PL, Hansen LM, Talat N, Hill PC, Hussain R, Adegbola RA, Flynn J, Canfield D, Parsonnet J. 2010. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One 5:e8804. doi:10.1371/journal.pone.0008804.
64. Mera RM, Correa P, Fontham EE, Reina JC, Pradilla A, Alzate A, Bravo LE. 2006. Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann. Epidemiol. 16:347-351.
65. Sood MR, Joshi S, Akobeng AK, Mitchell J, Thomas AG. 2005. Growth in children with Helicobacter pylori infection and dyspepsia. Arch. Dis. Child. 90:1025-1028.
66. Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. 2011. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment. Pharmacol. Ther. 33:922-929